why choose us

First received: August 31, 2023

Clinical Trial: A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hidradenitis Suppurativa

Study Type: INTERVENTIONAL


Official Title: A Parallel-group Treatment, Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAR444656 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Brief Summary: This is a parallel, Phase 2, 2-arm study to evaluate the efficacy, safety, PK, and biological effects of SAR444656 compared with placebo in adult participants with moderate to severe HS aged ?18 to 70 years.Study details include:Screening period: up to 4 weeks (30 days)Treatment duration: up to 16 weeksFollow-up period: up to 4 weeksTotal study duration: up to 24 weeksNumber of visits: 14

Read more